Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations

The British Journal of Surgery
S GansaugeH G Beger

Abstract

In patients suffering from chronic pancreatitis the risk for the development of pancreatic cancer ranges from 4 to 6 per cent. Various mutations are associated with pancreatic cancer, especially of p53 and K-ras. The incidence of these mutations in resected chronic pancreatitic tissue was investigated. In the present study DNA from 80 samples of tissue from patients with chronic pancreatitis was isolated and subjected to single-strand conformation polymorphism (SSCP) analysis of p53 exons 5-9 and restriction fragment length polymorphism analysis of K-ras (codon 12). No mutations in the K-ras gene were detected. On SSCP analysis, eight of 80 cases of chronic pancreatitis showed alterations (two in exon 5, four in exon 6, two in exon 7). DNA sequence analysis revealed one deletion of 21 amino acids (exon 5), four polymorphisms in exon 6 with no change in the amino acid sequence, one point mutation in exon 5, and two point mutations located in the intron between exons 6 and 7. These data show that in some cases of chronic pancreatitis mutations in the p53 gene occur without morphological evidence of pancreatic cancer.

References

Jan 1, 1992·Gastroenterology·N R LemoineG Klöppel
Feb 1, 1991·The Journal of Pathology·C M BartonN R Lemoine
Sep 1, 1988·The New England Journal of Medicine·B VogelsteinJ L Bos
Nov 1, 1987·Cancer·B Gudjonsson
May 3, 1987·Nature·J L BosB Vogelstein
Jan 15, 1985·Cancer·E B GoldD F Hutcheon
Dec 1, 1994·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·B V KallakuryJ Figge
Sep 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R MillikanL J Melton
Jun 9, 1995·Deutsche medizinische Wochenschrift·R M Schmid, G Adler
May 20, 1993·The New England Journal of Medicine·A B LowenfelsL Domellöf
Jun 1, 1996·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·S GansaugeH G Beger

❮ Previous
Next ❯

Citations

Nov 14, 2000·Diagnostic Cytopathology·C J Stewart, G M Burke
Dec 17, 2008·Cancer Causes & Control : CCC·Marta Crous-BouUNKNOWN PANKRAS II Study Group
Mar 21, 2000·Biochimica Et Biophysica Acta·S M Prescott, F A Fitzpatrick
Sep 20, 2001·International Immunopharmacology·F A Fitzpatrick
Oct 7, 2006·Current Opinion in Gastroenterology·R H HrubanS E Kern
Jul 23, 1999·Annals of the New York Academy of Sciences·J L van Laethem
Jul 18, 2002·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Lydie CostentinNicole Vaysse
Jul 18, 2002·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·T WongJ P Neoptolemos
Mar 12, 2008·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·D ParamythiotisH Friess
Jan 16, 1999·Baillière's Clinical Rheumatology·P Woo
Aug 20, 2003·Pathology, Research and Practice·Ernst HeinmöllerJosef Rüschoff
Jul 6, 2000·The American Journal of Pathology·E HeinmöllerJ Rüschoff
Feb 18, 2004·World Journal of Gastroenterology : WJG·De-Qing MuQiao-Jian Xu
Oct 7, 2006·Current Opinion in Gastroenterology·S T Chari, E P Dimagno
Nov 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kenoki OhuchidaMasao Tanaka
Nov 20, 2021·Clinical and Translational Gastroenterology·Robert W CowanAndrew D Rhim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.